Skip to main content
. 2022 Mar 22;23(7):3431. doi: 10.3390/ijms23073431
ACV acyclovir
ADCC antibody-dependent cell-mediated cytotoxicity
AMV Amenamevir
ATP adenosine triphosphate
BCDV brincidofovir
BVDU Brivudin
CDV cidofovir
CMV cytomegalovirus
CNS central nervous system
dNTPs deoxyribonucleotides triphosphate
dsDNA double-stranded DNA
EBV Epstein–Barr virus
EC50 half-maximal effective concentration
FCV famciclovir
FCV filociclovir
FDA Food and Drug Administration
FOS foscarnet
gB glycoprotein B
GCV ganciclovir
gD glycoprotein D
HBV hepatitis B virus
HHV6 human herpesvirus
HP helicase-primase complex
HPIs helicase-primase inhibitors
HPV human papillomavirus
HSC hematopoietic stem cell
HSV-1 herpes simplex virus type 1
HSV-2 herpes simplex virus type 2
IDU iododeoxyuridine
KSHV Kaposi’s sarcoma-associated herpesvirus
LMV letermovir
MBV maribavir
MBZM-N-IBT1 [(2-methyl benzimidazole-1-yl) methyl]-2-oxo-indolin-3-ylidene] amino] thiourea
MDV Marek’s disease virus
PCV penciclovir
PRV pseudorabies virus
PTV pritelivir
SOT solid organ transplant
ssDNA single-stranded DNA
TFD trifluridine
TK thymidine kinase
VACV valacyclovir
VDR vidarabine
VGCV valganciclovir
VZIG varicella-zoster immune globulin
VZV varicella-zoster virus